CHINA PHARMA HOLDINGS, INC. Interest Paid, Including Capitalized Interest, Operating and Investing Activities
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $410.51 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaid · last filed 2017-11-14
- CHINA PHARMA HOLDINGS, INC. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2017-06-30 was $271.55K, a 11.34% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2017-03-31 was $138.96K, a 42.65% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2016-12-31 was $146.24K, a 40.67% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2016 was $836.01K, a 27.41% decline from fiscal 2015.
- CHINA PHARMA HOLDINGS, INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2015 was $1.15M, a 6.43% decline from fiscal 2014.
- CHINA PHARMA HOLDINGS, INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2014 was $1.23M, a 115.98% increase from fiscal 2013.
- CHINA PHARMA HOLDINGS, INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2013 was $569.86K, a 90.95% increase from fiscal 2012.
| Period end | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 3 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 3 month as first filed | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 6 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 9 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month |
|---|---|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $271.55K derived: sum of 2 quarters · filed 2017-11-14 | $410.51K 10-Q · filed 2017-11-14 | $556.75K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2017-06-30 | $271.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $410.51K 10-Q · filed 2017-08-14 | $556.75K derived: sum of 3 quarters · filed 2017-08-14 | $760.33K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2017-03-31 | $138.96K 10-Q · filed 2017-05-11 | $285.20K derived: sum of 2 quarters · filed 2017-05-11 | $488.78K derived: sum of 3 quarters · filed 2017-11-14 | $732.67K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-12-31 | $146.24K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $349.82K derived: sum of 2 quarters · filed 2017-11-14 | $593.70K derived: sum of 3 quarters · filed 2017-11-14 | $836.01K 10-K · filed 2017-03-31 | |
| 2016-09-30 | $203.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $447.46K derived: sum of 2 quarters · filed 2017-11-14 | $689.77K 10-Q · filed 2017-11-14 | $936.24K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | $243.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $486.19K 10-Q · filed 2017-08-14 | $732.65K derived: sum of 3 quarters · filed 2017-08-14 | $1.01M derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | $242.31K 10-Q · filed 2017-05-11 | $1.15M 10-Q · filed 2016-05-16 | $488.77K derived: sum of 2 quarters · filed 2017-05-11 | $764.50K derived: sum of 3 quarters · filed 2017-05-11 | $163.12K derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | $246.46K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $522.19K derived: sum of 2 quarters · filed 2017-03-31 | -$79.19K derived: sum of 3 quarters · filed 2017-03-31 | $1.15M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $275.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$325.65K derived: sum of 2 quarters · filed 2016-11-14 | $905.15K 10-Q · filed 2016-11-14 | $1.19M derived: sum of 4 quarters · filed 2016-11-14 | |
| 2015-06-30 | -$601.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $629.42K 10-Q · filed 2016-08-11 | $916.97K derived: sum of 3 quarters · filed 2016-08-11 | $1.24M derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-03-31 | $1.23M 10-Q · filed 2016-05-16 | $310.39K 10-Q · filed 2015-05-11 | $1.52M derived: sum of 2 quarters · filed 2016-05-16 | $1.84M derived: sum of 3 quarters · filed 2016-05-16 | $2.19M derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | $287.55K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $608.96K derived: sum of 2 quarters · filed 2016-03-30 | $954.59K derived: sum of 3 quarters · filed 2016-03-30 | $1.23M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $321.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-28 | $667.04K derived: sum of 2 quarters · filed 2015-12-28 | $943.25K 10-Q · filed 2015-12-28 | $1.19M derived: sum of 4 quarters · filed 2015-12-28 | |
| 2014-06-30 | $345.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-28 | $621.84K 10-Q · filed 2015-12-28 | $867.58K derived: sum of 3 quarters · filed 2015-12-28 | $1.02M derived: sum of 4 quarters · filed 2015-12-28 | |
| 2014-03-31 | $276.21K 10-Q · filed 2015-12-28 | $521.95K derived: sum of 2 quarters · filed 2015-12-28 | $678.25K derived: sum of 3 quarters · filed 2015-12-28 | $734.72K derived: sum of 4 quarters · filed 2015-12-28 | |
| 2013-12-31 | $245.74K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-28 | $402.04K derived: sum of 2 quarters · filed 2015-12-28 | $458.51K derived: sum of 3 quarters · filed 2015-12-28 | $569.86K 10-K · filed 2015-12-28 | |
| 2013-09-30 | $156.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $212.77K derived: sum of 2 quarters · filed 2014-11-14 | $324.12K 10-Q · filed 2014-11-14 | $393.68K derived: sum of 4 quarters · filed 2014-11-14 | |
| 2013-06-30 | $56.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $167.82K 10-Q · filed 2014-08-14 | $237.38K derived: sum of 3 quarters · filed 2014-08-14 | $314.58K derived: sum of 4 quarters · filed 2014-08-14 | |
| 2013-03-31 | $111.35K 10-Q · filed 2013-05-14 | $180.91K derived: sum of 2 quarters · filed 2014-03-20 | $258.11K derived: sum of 3 quarters · filed 2014-03-20 | $334.21K derived: sum of 4 quarters · filed 2014-03-20 | |
| 2012-12-31 | $69.56K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $146.77K derived: sum of 2 quarters · filed 2014-03-20 | $222.87K derived: sum of 3 quarters · filed 2014-03-20 | $298.43K 10-K · filed 2014-03-20 | |
| 2012-09-30 | $77.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $153.31K derived: sum of 2 quarters · filed 2013-11-14 | $228.87K 10-Q · filed 2013-11-14 | $297.43K derived: sum of 4 quarters · filed 2013-11-14 | |
| 2012-06-30 | $76.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $151.67K 10-Q · filed 2013-08-14 | $220.22K derived: sum of 3 quarters · filed 2013-08-14 | $281.34K derived: sum of 4 quarters · filed 2013-08-14 | |
| 2012-03-31 | $75.57K 10-Q · filed 2013-05-14 | $144.12K derived: sum of 2 quarters · filed 2013-05-14 | $205.24K derived: sum of 3 quarters · filed 2013-05-14 | $265.42K derived: sum of 4 quarters · filed 2013-05-14 | |
| 2011-12-31 | $68.55K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $129.67K derived: sum of 2 quarters · filed 2013-03-14 | $189.85K derived: sum of 3 quarters · filed 2013-03-14 | $248.02K 10-K · filed 2013-03-14 | |
| 2011-09-30 | $61.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $121.30K derived: sum of 2 quarters · filed 2012-11-14 | $179.47K 10-Q · filed 2012-11-14 | $208.23K derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | $60.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $118.35K 10-Q · filed 2012-08-14 | $147.11K derived: sum of 3 quarters · filed 2012-08-14 | $184.48K derived: sum of 4 quarters · filed 2012-08-14 | |
| 2011-03-31 | $58.17K 10-Q · filed 2012-05-14 | $86.93K derived: sum of 2 quarters · filed 2012-05-14 | $124.31K derived: sum of 3 quarters · filed 2012-05-14 | ||
| 2010-12-31 | $28.76K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | $66.14K derived: sum of 2 quarters · filed 2012-03-14 | $168.26K 10-K · filed 2012-03-14 | ||
| 2010-09-30 | $37.37K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06 | $139.49K 10-Q/A · filed 2012-03-06 | |||
| 2010-06-30 | $102.12K 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |